Use this form to request a free consultation with a qualified attorney near you.
ATTORNEY ADVERTISING -
Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.
800-889-3898
Hydroxycut® and ephedra have a long history. Before the FDA banned the sale of dietary supplements containing ephedra in 2004, Hydroxycut® products often contained ephedra, a plant-derived ingredient heavily marketed as an energy-enhancing supplement.
Ephedra was in Hydroxycut®'s "energy" and weight loss pills, powders, and drinks. Known in Chinese herbal medicine as "ma huang," ephedra is a source of ephedrine, a stimulant. Ephedrine constricts the body's blood vessels and thus increases one's blood pressure and heart rate. It also expands the lungs' bronchial tubes, which explains the centuries-old use in China of ma huang for asthma.
The potential Hydroxycut® side effects of ephedra were the basis of the FDA's ban. The side effects and adverse medical events linked to Hydroxycut® ephedra included:
It is now illegal to sell dietary supplements (such as Hydroxycut®) with ephedra in the U.S. Distributors such as MuscleTech and the manufacturer Iovate Health Sciences, Inc. now market "ephedra-free Hydroxycut®" products. Other ingredients have taken the place of the ephedra — ingredients such as garcinia cambogia and green tea.
Despite the apparent removal of ephedra from Hydroxycut® products, serious adverse events linked to Hydroxycut® continued to be reported to the FDA. Over 20 reports of liver damage and one death associated with Hydroxycut® prompted the FDA to recommend in early May 2009 that U.S. consumers stop using all Hydroxycut® products.
In addition, Iovate Health Science voluntarily recalled 14 of its Hydroxycut® products on the U.S. market:
Have you or a loved one been injured after using Hydroxycut®? If so, contact us to speak with an experienced Hydroxycut® attorney who specializes in drug recall litigation & lawsuits. Let us help you win the compensation you need and deserve.